查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2083959

經導管醫療設備市場：2026-2032 年全球市場預測，依產品類型、入路途徑、材質、病患類型、應用、最終用戶和分銷管道分類。

Transcatheter Devices Market by Product Type, Access Route, Material Type, Patient Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，經導管醫療設備市場將成長至 243.3 億美元，複合年成長率為 10.44%。

主要市場統計數據
基準年 2025 121.4億美元
預計年份：2026年 133.8億美元
預測年份 2032 243.3億美元
複合年成長率 (%) 10.44%

經導管醫療設備執行摘要

經導管醫療設備正在改變結構性心臟病、血管疾病和神經血管心臟疾病的治療方式，透過導管介入，可以進行瓣膜修復和置換、左心耳封堵、室間隔缺損封堵、栓塞術、血栓切除術以及其他微創手術。持續的臨床需求是推動這一市場發展的動力。心血管疾病仍是全球首要死因，世界衛生組織（WHO）估計，每年約有1,790萬人死於心血管疾病。

經導管醫療設備領域的變革性變化

經導管醫療設備領域正從單一手術創新轉向整合式治療路徑，將先進的影像技術、器材工程、導航和時間序列病患監測相結合。小型化輸送系統、可重新定位的植入、可回收的支架、改進的密封技術以及更高的輸送精度，不僅擴大了這些器械的適用患者群體，也幫助臨床醫生應對複雜的解剖結構。

人工智慧（AI）的累積影響

人工智慧（AI）不再只是一個獨立的市場主題；它正在成為經導管醫療設備領域的一股實際驅動力。人工智慧驅動的心臟超音波圖、CT分割、透視引導和手術規劃工具能夠更一致地量化瓣環尺寸、瓣葉解剖結構、血管通路適用性、血栓體積和器械尺寸選擇。

對關鍵區域的洞察

亞太地區為經導管醫療設備提供了最具活力的機遇，中國、日本、印度、韓國和澳洲正面臨著人口老化、心血管疾病負擔日益加重以及需要擴大先進心臟介入治療覆蓋範圍等挑戰。日本和澳洲受益於成熟的保險報銷系統、完善的專科醫療中心和以指南為基礎的心臟護理。同時，中國和印度正在擴大國內生產、加強醫生培訓並建立大規模醫院網路，以改善經導管主動脈瓣置換術術、二尖瓣修復術、左心耳封堵術、栓塞術和血栓切除術的可及性。

主要群體分析

隨著新加坡、泰國、馬來西亞、印尼、越南和菲律賓等國提升導管室容量、投資三級心臟護理服務以及微創心血管治療，東協地區的需求正在增加。然而，醫療服務的可及性因保險報銷系統、醫生密度和都市區而異。在海灣合作理事會（GCC）國家、沙烏地阿拉伯、阿拉伯聯合大公國、卡達及其周邊市場，各國正透過醫院現代化建設高品質的心血管計畫。這通常得益於國際臨床合作、對先進影像技術的投資以及對縮短住院時間的微創手術日益成長的偏好。

主要國家的概況

美國作為單一國家，在經導管醫療設備領域擁有最大的市場機遇，這得益於其龐大的手術量、強大的臨床試驗網路、完善的聯邦醫療保險（Medicare）福利計劃、專業的心臟中心，以及結構性心臟疾病和血管內治療技術的快速普及。在加拿大，省級醫保報銷計畫和專科中心正穩步推進經導管醫療器材的普及；而在墨西哥和巴西，領先的私立醫院和部分公共計畫正在擴大經導管醫療器材的覆蓋範圍，尤其是在介入性心臟病學和先進診斷影像技術專家雲集的大都會圈。

為行業領導者提供的實用建議

產業領導者應優先考慮反映實際解剖結構、共病、疾病嚴重程度和不同醫師間差異的臨床證據。雖然隨機試驗仍然至關重要，但註冊研究、上市後監測、健康經濟學研究和以病人為中心的結局指標在決定報銷、採購決策和醫院部署方面變得越來越重要。

調查方法

本執行摘要基於系統的二手研究方法，利用了最新的公開監管資訊、臨床指南、同行評審文獻、醫院採納趨勢、政府衛生統計數據、報銷政策以及來自權威公共衛生資訊來源的疾病負擔數據。市場分析重點關注已證實的市場研究途徑，包括心血管疾病負擔、人口老化、微創手術的興起、結構性心臟介入治療證據的不斷積累以及先進影像技術在導管介入治療中日益廣泛的應用。

結論

經導管醫療設備正從特殊用途的替代方案轉變為心血管、結構性心臟疾病、血管和神經血管治療的核心要素。其最大的發展機會源於人口老化、結構性心臟疾病計畫的擴展、影像技術的進步、人工智慧驅動的治療計劃、醫務人員培訓以及對微創治療日益成長的需求，這些微創治療能夠縮短特定患者的康復時間。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 經導管醫療設備市場：依產品類型分類

  • 配送系統
    • 基於導管的系統
    • 鞘套底座系統
  • 栓塞預防裝置
    • 過濾式保護裝置
    • 用於阻塞的球囊裝置
    • 近端保護裝置
  • 遮蔽器
    • 心房中膈缺損症封堵裝置
    • 左心耳封堵裝置
    • 卵圓通暢性閉合裝置
  • 血管閉合裝置
    • 血管外夾
    • 血管內栓塞
    • 使用縫合線的系統

第8章 經導管醫療設備市場：以入路方式分類

  • 股動脈
  • 經心尖
  • 股動脈
  • 經頸靜脈
  • 經隔膜

第9章 經導管醫療設備市場：依材質

  • 金屬
    • 不銹鋼
    • 鈷
  • 聚合物
    • 聚氨酯
    • 聚四氟乙烯
  • 生物來源/組織來源
    • 牛
    • 豬

第10章 經導管醫療設備市場：依病患類型分類

  • 成人
  • 兒童
  • 老年人

第11章 經導管醫療設備市場：依應用領域分類

  • 主動脈瓣置換術
  • 心房中膈缺損症封堵術
  • 左心耳封堵術
  • 二尖瓣修復
  • 卵圓孔未通暢性
  • 肺動脈瓣置換術
  • 三尖瓣修復

第12章 經導管醫療設備市場：依最終用戶分類

  • 門診手術中心
  • 心臟病診所
  • 醫院

第13章 經導管醫療設備市場：依通路分類

  • 直銷
  • 銷售代理

第14章 經導管醫療設備市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第15章 經導管醫療設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 經導管醫療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • Abbott Laboratories
  • Anteris Technologies Ltd.
  • Artivion, Inc.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Braile Biomedica Industria & Comercio SA
  • CardioKinetix Inc.
  • Cardiovalve Ltd.
  • Colibri Heart Valve LLC
  • Cook Medical LLC
  • Edwards Lifesciences Corporation
  • HighLife SAS
  • InnovHeart Srl
  • JenaValve Technology, Inc.
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Merit Medical Systems, Inc.
  • Micro Interventional Devices, Inc.
  • MicroPort Scientific Corporation
  • NaviGate Cardiac Structures, Inc.
  • Neovasc Inc.
  • Peijia Medical Limited
  • Symetis SA
  • Terumo Corporation
  • Venus Medtech Inc.
  • WL Gore & Associates, Inc.
  • Xeltis AG
Product Code: MRR-436145BF8BB5

The Transcatheter Devices Market is projected to grow by USD 24.33 billion at a CAGR of 10.44% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 12.14 billion
Estimated Year [2026] USD 13.38 billion
Forecast Year [2032] USD 24.33 billion
CAGR (%) 10.44%

Transcatheter Devices Executive Summary

Transcatheter devices are reshaping structural heart, vascular, and neurovascular care by enabling valve repair and replacement, left atrial appendage closure, septal defect closure, embolization, thrombectomy, and other minimally invasive interventions through catheter-based access. The market is supported by a durable clinical need: cardiovascular disease remains the leading global cause of death, with the World Health Organization estimating approximately 17.9 million deaths annually from cardiovascular conditions.

Demand is rising as health systems prioritize shorter hospital stays, faster recovery, reduced procedural trauma, and lower dependence on open surgery for eligible patients. Transcatheter aortic valve replacement, transcatheter edge-to-edge mitral repair, transcatheter pulmonary valve replacement, and left atrial appendage occlusion have moved from niche options for inoperable or high-risk patients toward broader use in carefully selected populations, supported by randomized trials, registry evidence, and guideline updates.

Transformative Shifts in the Transcatheter Device Landscape

The transcatheter devices landscape is shifting from procedure-by-procedure innovation to integrated care pathways that combine advanced imaging, device engineering, navigation, and longitudinal patient monitoring. Miniaturized delivery systems, repositionable implants, retrievable frames, improved sealing technologies, and enhanced delivery precision are expanding patient eligibility while helping clinicians manage complex anatomy.

A second major shift is the migration of procedures into earlier disease stages and lower-risk cohorts where evidence supports clinical benefit. This evolution increases the importance of lifetime device management, durability data, reintervention planning, and multidisciplinary heart team decision-making. Manufacturers that demonstrate reproducible outcomes across diverse centers, not only elite academic hospitals, are better positioned for adoption.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical enabler in transcatheter devices rather than a stand-alone market theme. AI-assisted echocardiography, CT segmentation, fluoroscopy guidance, and procedural planning tools can help quantify annular dimensions, leaflet anatomy, vascular access suitability, thrombus burden, and device sizing with greater consistency.

The cumulative impact is expected across the full value chain: faster image interpretation, more standardized patient selection, improved cath lab workflow, better complication anticipation, and stronger post-market surveillance using real-world evidence. However, AI adoption depends on transparent validation, cybersecurity, clinician oversight, interoperability, and regulatory alignment because device selection and procedural guidance remain high-stakes clinical decisions.

Key Regional Insights

Asia-Pacific is one of the most dynamic opportunity zones for transcatheter devices as China, Japan, India, South Korea, and Australia address aging populations, rising cardiovascular disease burden, and widening access to advanced interventional cardiology. Japan and Australia benefit from mature reimbursement structures, established specialist centers, and guideline-driven cardiac care, while China and India are scaling domestic manufacturing, physician training, and high-volume hospital networks to improve access to transcatheter aortic valve replacement, mitral repair, left atrial appendage occlusion, embolization, and thrombectomy procedures.

North America remains a leading innovation and adoption hub, anchored by U.S. FDA pathways, strong clinical trial infrastructure, established reimbursement mechanisms, and broad use of TAVR, TEER, LAAO, and neurovascular thrombectomy technologies. Europe benefits from advanced structural heart programs, multidisciplinary valve teams, and CE-mark commercialization pathways, although evidence requirements have tightened under the EU Medical Device Regulation. Latin America, the Middle East, and Africa present selective expansion opportunities led by private hospitals, public-private investment, and specialist referral centers, with adoption shaped by reimbursement availability, import dependence, procurement capacity, hospital infrastructure, and operator training.

Key Group Insights

ASEAN demand is expanding as Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines invest in cath lab capacity, tertiary cardiac services, and minimally invasive cardiovascular procedures, although access varies by reimbursement, physician density, and urban concentration. The GCC is building premium cardiovascular programs through hospital modernization in Saudi Arabia, the United Arab Emirates, Qatar, and neighboring markets, often supported by international clinical partnerships, advanced imaging investments, and growing preference for less invasive procedures that reduce hospitalization time.

The European Union remains important for regulatory harmonization, clinical evidence generation, health technology assessment, and cross-border procurement, while BRICS countries are increasingly relevant for procedure volume growth, local manufacturing, and cost-sensitive device design. G7 markets continue to set benchmarks for reimbursement, outcomes reporting, regulatory science, and innovation adoption. NATO countries overlap heavily with high-income hospital systems where supply chain resilience, cybersecurity, procurement transparency, and continuity of critical medical technologies are becoming strategic priorities for transcatheter device stakeholders.

Key Country Insights

The United States is the largest single-country opportunity for transcatheter devices due to high procedure volumes, strong trial networks, Medicare coverage mechanisms, specialist heart centers, and rapid uptake of structural heart and endovascular technologies. Canada shows steady adoption through provincial reimbursement and specialized centers, while Mexico and Brazil are expanding access through leading private hospitals and selected public programs, particularly in major metropolitan areas where interventional cardiology expertise and advanced imaging are concentrated.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain advanced structural heart ecosystems supported by trained operators, hospital-based heart teams, and established referral pathways, with Germany particularly known for high TAVR penetration and extensive cardiology infrastructure. Russia remains constrained by geopolitical, procurement, and supply chain dynamics. In Asia-Pacific, China is scaling quickly through domestic innovation, large patient pools, and expanding tertiary hospital capacity; India is driven by affordability needs, high cardiovascular disease burden, and unmet access; Japan emphasizes quality, aging-related demand, and rigorous clinical practice; South Korea supports advanced medical technology adoption and hospital modernization; and Australia benefits from guideline-based care, established reimbursement, and strong specialist networks.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinical evidence that reflects real-world anatomy, comorbidity, disease severity, and operator variability. Randomized trials remain essential, but registries, post-market surveillance, health economic studies, and patient-centered outcome measures increasingly determine reimbursement, procurement decisions, and hospital adoption.

Manufacturers should invest in lower-profile delivery systems, retrievability, repositionability, sealing performance, imaging compatibility, and lifetime management strategies. Commercial teams should pair device launches with physician education, proctoring, cath lab workflow support, and multidisciplinary heart team engagement. In emerging markets, success depends on tiered pricing, local partnerships, regulatory readiness, service infrastructure, and programs that expand training beyond flagship hospitals.

Research Methodology

This executive summary is based on a structured secondary research approach using publicly available regulatory updates, clinical guidelines, peer-reviewed literature, hospital adoption patterns, government health statistics, reimbursement policies, and disease burden data from recognized public health sources. Market interpretation emphasizes verified drivers such as cardiovascular disease burden, aging demographics, minimally invasive procedure adoption, structural heart intervention evidence, and the growing role of advanced imaging in catheter-based therapies.

Insights were synthesized across regional, group, and country dimensions to identify demand signals, access barriers, reimbursement dynamics, technology trends, regulatory considerations, and competitive priorities. The analysis avoids unsupported market-size claims and focuses on directional, evidence-based conclusions relevant to manufacturers, providers, investors, payers, and policy stakeholders.

Conclusion

Transcatheter devices are moving from specialized alternatives to core components of cardiovascular, structural heart, vascular, and neurovascular care. The strongest opportunities are linked to aging populations, expanding structural heart programs, improved imaging, AI-enabled planning, operator training, and rising demand for minimally invasive therapies that can reduce recovery time for appropriately selected patients.

Winning strategies will depend on clinically differentiated devices, durable outcomes, reimbursement evidence, post-market safety data, physician education, and region-specific execution. Organizations that combine innovation with proof of value, safety, and scalable adoption will be best positioned in the next phase of the transcatheter devices market.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Transcatheter Devices Market, by Product Type

  • 7.1. Delivery System
    • 7.1.1. Catheter Based Systems
    • 7.1.2. Sheath Based Systems
  • 7.2. Embolic Protection Device
    • 7.2.1. Filter Based Protection
    • 7.2.2. Occlusion Balloon Device
    • 7.2.3. Proximal Protection Device
  • 7.3. Occluder
    • 7.3.1. Atrial Septal Defect Occluder
    • 7.3.2. Left Atrial Appendage Occluder
    • 7.3.3. Patent Foramen Ovale Occluder
  • 7.4. Vascular Closure Device
    • 7.4.1. Extravascular Clips
    • 7.4.2. Intravascular Plugs
    • 7.4.3. Suture Based Systems

8. Transcatheter Devices Market, by Access Route

  • 8.1. Transaortic
  • 8.2. Transapical
  • 8.3. Transfemoral
  • 8.4. Transjugular
  • 8.5. Transseptal

9. Transcatheter Devices Market, by Material Type

  • 9.1. Metal
    • 9.1.1. Stainless Steel
    • 9.1.2. Cobalt
  • 9.2. Polymer
    • 9.2.1. Polyurethane
    • 9.2.2. Polytetrafluoroethylene
  • 9.3. Biological / Tissue-Based
    • 9.3.1. Bovine
    • 9.3.2. Porcine

10. Transcatheter Devices Market, by Patient Type

  • 10.1. Adult
  • 10.2. Pediatric
  • 10.3. Geriatric

11. Transcatheter Devices Market, by Application

  • 11.1. Aortic Valve Replacement
  • 11.2. Atrial Septal Defect Closure
  • 11.3. Left Atrial Appendage Occlusion
  • 11.4. Mitral Valve Repair
  • 11.5. Patent Foramen Ovale Closure
  • 11.6. Pulmonary Valve Replacement
  • 11.7. Tricuspid Valve Repair

12. Transcatheter Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Cardiac Specialty Clinics
  • 12.3. Hospitals

13. Transcatheter Devices Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors

14. Transcatheter Devices Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. North America
  • 14.3. Latin America
  • 14.4. Europe
  • 14.5. Middle East
  • 14.6. Africa

15. Transcatheter Devices Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Transcatheter Devices Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. Abbott Laboratories
  • 18.2. Anteris Technologies Ltd.
  • 18.3. Artivion, Inc.
  • 18.4. Biotronik SE & Co. KG
  • 18.5. Boston Scientific Corporation
  • 18.6. Braile Biomedica Industria & Comercio S.A.
  • 18.7. CardioKinetix Inc.
  • 18.8. Cardiovalve Ltd.
  • 18.9. Colibri Heart Valve LLC
  • 18.10. Cook Medical LLC
  • 18.11. Edwards Lifesciences Corporation
  • 18.12. HighLife SAS
  • 18.13. InnovHeart S.r.l.
  • 18.14. JenaValve Technology, Inc.
  • 18.15. Lepu Medical Technology (Beijing) Co., Ltd.
  • 18.16. Medtronic plc
  • 18.17. Meril Life Sciences Pvt. Ltd.
  • 18.18. Merit Medical Systems, Inc.
  • 18.19. Micro Interventional Devices, Inc.
  • 18.20. MicroPort Scientific Corporation
  • 18.21. NaviGate Cardiac Structures, Inc.
  • 18.22. Neovasc Inc.
  • 18.23. Peijia Medical Limited
  • 18.24. Symetis SA
  • 18.25. Terumo Corporation
  • 18.26. Venus Medtech Inc.
  • 18.27. W. L. Gore & Associates, Inc.
  • 18.28. Xeltis AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL TRANSCATHETER DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL TRANSCATHETER DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL TRANSCATHETER DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL TRANSCATHETER DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSCATHETER DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL TRANSCATHETER DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY PATIENT TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DELIVERY SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DELIVERY SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CATHETER BASED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CATHETER BASED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CATHETER BASED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SHEATH BASED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SHEATH BASED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SHEATH BASED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL EMBOLIC PROTECTION DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL EMBOLIC PROTECTION DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL EMBOLIC PROTECTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FILTER BASED PROTECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FILTER BASED PROTECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FILTER BASED PROTECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL OCCLUSION BALLOON DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL OCCLUSION BALLOON DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL OCCLUSION BALLOON DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PROXIMAL PROTECTION DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PROXIMAL PROTECTION DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PROXIMAL PROTECTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL OCCLUDER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL OCCLUDER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL OCCLUDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ATRIAL SEPTAL DEFECT OCCLUDER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ATRIAL SEPTAL DEFECT OCCLUDER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ATRIAL SEPTAL DEFECT OCCLUDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LEFT ATRIAL APPENDAGE OCCLUDER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LEFT ATRIAL APPENDAGE OCCLUDER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LEFT ATRIAL APPENDAGE OCCLUDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PATENT FORAMEN OVALE OCCLUDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL EXTRAVASCULAR CLIPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL EXTRAVASCULAR CLIPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL EXTRAVASCULAR CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTRAVASCULAR PLUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAVASCULAR PLUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTRAVASCULAR PLUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SUTURE BASED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SUTURE BASED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SUTURE BASED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL TRANSAORTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL TRANSAORTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL TRANSAORTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL TRANSAPICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL TRANSAPICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL TRANSAPICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL TRANSFEMORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL TRANSFEMORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL TRANSFEMORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL TRANSJUGULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL TRANSJUGULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL TRANSJUGULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL TRANSSEPTAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL TRANSSEPTAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL TRANSSEPTAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL METAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL METAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL METAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL STAINLESS STEEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL STAINLESS STEEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL STAINLESS STEEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL COBALT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL COBALT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL COBALT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL POLYMER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL POLYMER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL POLYMER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL POLYURETHANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL POLYURETHANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL POLYTETRAFLUOROETHYLENE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL POLYTETRAFLUOROETHYLENE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL POLYTETRAFLUOROETHYLENE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOLOGICAL / TISSUE-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BIOLOGICAL / TISSUE-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOLOGICAL / TISSUE-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BOVINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BOVINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BOVINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PORCINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PORCINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PORCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL AORTIC VALVE REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL AORTIC VALVE REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL AORTIC VALVE REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ATRIAL SEPTAL DEFECT CLOSURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ATRIAL SEPTAL DEFECT CLOSURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ATRIAL SEPTAL DEFECT CLOSURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL LEFT ATRIAL APPENDAGE OCCLUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL LEFT ATRIAL APPENDAGE OCCLUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL LEFT ATRIAL APPENDAGE OCCLUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL MITRAL VALVE REPAIR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MITRAL VALVE REPAIR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL MITRAL VALVE REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PATENT FORAMEN OVALE CLOSURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PATENT FORAMEN OVALE CLOSURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PATENT FORAMEN OVALE CLOSURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PULMONARY VALVE REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PULMONARY VALVE REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL PULMONARY VALVE REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL TRICUSPID VALVE REPAIR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL TRICUSPID VALVE REPAIR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL TRICUSPID VALVE REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL CARDIAC SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL CARDIAC SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL CARDIAC SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL DISTRIBUTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL DISTRIBUTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC TRANSCATHETER DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC TRANSCATHETER DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC TRANSCATHETER DEVICES MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC TRANSCATHETER DEVICES MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC TRANSCATHETER DEVICES MARKET SIZE, BY BIOLOGICAL / TISSUE-BASED, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC TRANSCATHETER DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA TRANSCATHETER DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY BIOLOGICAL / TISSUE-BASED, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA TRANSCATHETER DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY BIOLOGICAL / TISSUE-BASED, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE TRANSCATHETER DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE TRANSCATHETER DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE TRANSCATHETER DEVICES MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE TRANSCATHETER DEVICES MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE TRANSCATHETER DEVICES MARKET SIZE, BY BIOLOGICAL / TISSUE-BASED, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE TRANSCATHETER DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST TRANSCATHETER DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST TRANSCATHETER DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST TRANSCATHETER DEVICES MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST TRANSCATHETER DEVICES MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST TRANSCATHETER DEVICES MARKET SIZE, BY BIOLOGICAL / TISSUE-BASED, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST TRANSCATHETER DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA TRANSCATHETER DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY BIOLOGICAL / TISSUE-BASED, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 232. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN TRANSCATHETER DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN TRANSCATHETER DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN TRANSCATHETER DEVICES MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN TRANSCATHETER DEVICES MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN TRANSCATHETER DEVICES MARKET SIZE, BY BIOLOGICAL / TISSUE-BASED, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN TRANSCATHETER DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 248. GCC TRANSCATHETER DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 249. GCC TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. GCC TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 251. GCC TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 252. GCC TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 253. GCC TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2032 (USD MILLION)
  • TABLE 254. GCC TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 255. GCC TRANSCATHETER DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. GCC TRANSCATHETER DEVICES MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 257. GCC TRANSCATHETER DEVICES MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 258. GCC TRANSCATHETER DEVICES MARKET SIZE, BY BIOLOGICAL / TISSUE-BASED, 2018-2032 (USD MILLION)
  • TABLE 259. GCC TRANSCATHETER DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. GCC TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. GCC TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. GCC TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION TRANSCATHETER DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION TRANSCATHETER DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION TRANSCATHETER DEVICES MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION TRANSCATHETER DEVICES MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION TRANSCATHETER DEVICES MARKET SIZE, BY BIOLOGICAL / TISSUE-BASED, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION TRANSCATHETER DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 278. BRICS TRANSCATHETER DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS TRANSCATHETER DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS TRANSCATHETER DEVICES MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS TRANSCATHETER DEVICES MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS TRANSCATHETER DEVICES MARKET SIZE, BY BIOLOGICAL / TISSUE-BASED, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS TRANSCATHETER DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 293. G7 TRANSCATHETER DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 294. G7 TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. G7 TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 296. G7 TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 297. G7 TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 298. G7 TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2032 (USD MILLION)
  • TABLE 299. G7 TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 300. G7 TRANSCATHETER DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. G7 TRANSCATHETER DEVICES MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 302. G7 TRANSCATHETER DEVICES MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 303. G7 TRANSCATHETER DEVICES MARKET SIZE, BY BIOLOGICAL / TISSUE-BASED, 2018-2032 (USD MILLION)
  • TABLE 304. G7 TRANSCATHETER DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. G7 TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 306. G7 TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 307. G7 TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 308. NATO TRANSCATHETER DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 309. NATO TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 310. NATO TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 311. NATO TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 312. NATO TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 313. NATO TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2032 (USD MILLION)
  • TABLE 314. NATO TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 315. NATO TRANSCATHETER DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 316. NATO TRANSCATHETER DEVICES MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 317. NATO TRANSCATHETER DEVICES MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 318. NATO TRANSCATHETER DEVICES MARKET SIZE, BY BIOLOGICAL / TISSUE-BASED, 2018-2032 (USD MILLION)
  • TABLE 319. NATO TRANSCATHETER DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. NATO TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 321. NATO TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 322. NATO TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 323. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 324. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 325. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 326. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 327. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 328. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 329. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2032 (USD MILLION)
  • TABLE 330. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 331. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 333. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 334. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY BIOLOGICAL / TISSUE-BASED, 2018-2032 (USD MILLION)
  • TABLE 335. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 336. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 337. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 338. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 339. CANADA TRANSCATHETER DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 340. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 341. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 342. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 343. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 344. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2032 (USD MILLION)
  • TABLE 345. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
  • TABLE 346. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 347. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 348. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 349. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY BIOLOGICAL / TISSUE-BASED, 2018-2032 (USD MILLION)
  • TABLE 350. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 351. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 352. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 353. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 354. MEXICO TRANSCATHETER DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 355. MEXICO TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 356. MEXICO TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 357. MEXICO TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE,